Nurix Therapeutics, Inc.Nurix Therapeutics, Inc.Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

No trades
See on Supercharts

Price target

31.200.000.00%
The 15 analysts offering 1 year price forecasts for NRIX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to NRIX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NRIX EPS for the last quarter is −0.67 USD despite the estimation of −0.69 USD. In the next quarter EPS is expected to reach −0.67 USD. Track more of Nurix Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Nurix Therapeutics, Inc. revenue is expected to reach ‪15.37 M‬ USD. Check out Nurix Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, NRIX price target is 31.20 USD with a max estimate of 41.00 USD and a min estimate of 16.00 USD. Check if this forecast comes true in a year, meanwhile watch Nurix Therapeutics, Inc. stock price chart and keep track of the current situation with NRIX news and stock market news.
We've gathered opinions of 15 analysts rating NRIX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.